Lonza’s Record Performance Sparks Investor Optimism and Valuation Questions
Swiss pharmaceutical services provider Lonza has delivered exceptional first-half 2025 results, prompting upward revisions to its annual forecasts. The company's ...
© 2024 Stocks Today